Johnson & Johnson Remains a Top Holding for Rede Wealth LLC

Investment firm significantly increases stake in pharmaceutical giant in Q4 2025

Apr. 18, 2026 at 9:56am

Got story updates? Submit your updates here. ›

A black and white close-up photograph of the intricate gears, valves, and other industrial machinery that powers a modern pharmaceutical production facility, conveying the scale and precision required to manufacture Johnson & Johnson's diverse range of healthcare products.The complex, high-tech machinery that underpins Johnson & Johnson's pharmaceutical and medical device manufacturing capabilities.New Brunswick Today

Rede Wealth LLC, a prominent investment management firm, significantly increased its position in Johnson & Johnson (NYSE: JNJ) during the fourth quarter of 2025, making the pharmaceutical company its fourth-largest holding. The fund added over 32,000 shares, bringing its total JNJ holdings to 37,085 shares worth $7.675 million.

Why it matters

Johnson & Johnson's inclusion as a top holding for Rede Wealth LLC highlights the continued investor confidence in the company's pharmaceutical and medical device businesses, which have weathered the challenges of the past few years. The significant increase in Rede Wealth's position suggests the firm sees strong long-term growth potential in JNJ.

The details

According to a recent SEC filing, Rede Wealth LLC increased its position in Johnson & Johnson by 754.1% in the fourth quarter of 2025. The firm now owns 37,085 shares of the company's stock, making it the fourth-largest holding in its investment portfolio. Johnson & Johnson comprises 2.7% of Rede Wealth's total assets under management.

  • Rede Wealth LLC increased its JNJ holdings in the fourth quarter of 2025.
  • The firm's SEC filing detailing the position increase was published on April 18, 2026.

The players

Rede Wealth LLC

A prominent investment management firm that has significantly increased its stake in Johnson & Johnson.

Johnson & Johnson

A multinational healthcare company that develops, manufactures, and markets pharmaceutical, medical device, and consumer health products.

Got photos? Submit your photos here. ›

The takeaway

Rede Wealth's substantial increase in its Johnson & Johnson holdings underscores the continued investor confidence in the company's diversified healthcare business model and growth prospects. As a top-four position in the firm's portfolio, JNJ is seen as a core long-term holding with the potential to deliver steady returns.